There are no studies on the use of complementary and alternative medicine (CAM) therapies in subjects with inherited metabolic disease (IMD) in the current literature. This study aimed to determine the type, frequency of and reasons for the use, and factors associated with the use of CAM therapies.
Subjects included in this study consisted of 335 children (95.7%) and 15 (4.3%) adults with a median age of 5.66±6.16 (0.08–48) years with inherited metabolic disease. A single physician conducted face-to-face interviews with the mother and/or father for pediatric subjects and with the subjects themselves for adults of a normal intelligence. Data were obtained from responses to the questions in the standard survey form.
Our study included 350 patients in total, of whom 164 (46.9%) were female and 186 (53.1%) male. We found that 144 of the patients (41.1%) had used at least one CAM therapy method. The highest rate of use among the CAM therapy methods was of the mind-body approach therapies (n=98, 28%). This was followed by biologically-based (n=75, 21.4%) and manipulative and body-based (n=5, 1.4%) therapies, respectively. The most commonly used herbal product was herbal tea (n=21, 6%), and the most commonly used dietary supplementation was a royal jelly and pollen mixture (n=9, 2.6%). Significant differences in the subjects’ age, their follow-up duration, their mother’s and father’s ages, and CAM therapy use were identified from sociodemographic data.
In our study, the use of CAM therapies was determined at a high rate. This is important when dealing with clinical problems and for clinicians who follow-up with IMD subjects and suspect they may be using CAM therapy.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
1. Kelly KM. Bringing evidence to complementary and alternative medicine in children with cancer: focus on nutrion-related therapies. Pediatr Blood Cancer 2008;50:490–3. Search in Google Scholar
2. Wong C. Five types of Complementary and Alternative Medicine. 12 February 2016. Available at: http://altmedicine.about.com/od/alternativemedicinebasics/a/types.htm. Accessed: 01 January 2018. Search in Google Scholar
3. Kelly KM, Jacobsan JS, Kennendy DD, Braudt SM, Mallick M, et al. Use of unconventional therapies by children with cancer at an urban medical center. J Pediatr Hematol Oncol 2000;22:412–6. Search in Google Scholar
4. Kelly KM. Comlementary and alternative medicines for use in supportive care in pediatric cancer. Support Care Cancer 2007;15:457–60. Search in Google Scholar
5. Vlieger AM, Blink M, Tromp E, Benninga MA. Use of complementary and alternative medicine by pediatric patients with functional and organic gastrointestinal diseases: results from a multicenter survey. Pediatrics 2008;122:446–51. Search in Google Scholar
6. Bahall M. Prevalence, patterns, and perceived value of complementary and alternative medicine among HIV patients: a descriptive study. BMC Complement Altern Med 2017;17:422. Search in Google Scholar
7. Kamel FO, Magadmi RM, Hagras MM, Magadmi B, AlAhmad RA. Knowledge, attitude, and beliefs toward traditional herbal medicine use among diabetics in Jeddah Saudi Arabia. Complement Ther Clin Pract 2017;29:207–12. Search in Google Scholar
8. Ayele AA, Tegegn HG, Haile KT, Belachew SA, Mersha AG, et al. Complementary and alternative medicine use among elderly patients living with chronic diseases in a teaching hospital in Ethiopia. Complement Ther Med 2017;35: 115–9. Search in Google Scholar
9. Balwani M, Fuerstman L, Desnick RJ, Buckley B, Margaret MG. Use of complementary and alternative medicine by patients with lysosomal storage diseases. Genet Med 2009; 11:722–7. Search in Google Scholar
10. Saudubray JM, Cazorla AG. Clinical approach to inborn errors of metabolism in pediatrics. In: Saudubray JM, Baumgartner MR, Walter John H, editors. Inborn metabolic diseases. Berlin: Springer-Verlag, 2016:3–69. Search in Google Scholar
11. Kemppainen LM, Kemppainen TT, Reippainen JA, Salmenniemi ST, Vuolanto PH. Use of complementary and alternative medicine in Europe: health-related and sociodemographic determinants. Scand J Public Health 2018;46:448–55. Search in Google Scholar
12. Sobo EJ. Parent use of cannabis for intractable pediatric epilepsy: everyday empiricism and the boundaries of scientific medicine. Soc Sci Med 2017;190:190–8. Search in Google Scholar
13. Judaki A, Rahmani A, Feizi J, Asadollahi K, Hafezi Ahmadi MR. Curcumin in combination with triple therapy regimes ameliorates oxidative stress and histopathologic changes in chronic gastritis-associated Helicobacter pylori infection. Arq Gastroenterol 2017;54:177–82. Search in Google Scholar
14. Cheifetz AS, Gianotti R, Luber R, Gibson PR. Complementary and alternative medicines used by patients with inflammatory bowel diseases. Gastroenterology 2017;152:415–29. Search in Google Scholar
15. Damião AO. Complementary and alternative medicine: a world to be explored. Arq Gastroenterol 2017;54:175–6. Search in Google Scholar
©2018 Walter de Gruyter GmbH, Berlin/Boston